pCW-IRF4-Puro
(Plasmid
#123323)
-
PurposeLentiviral vector for expression of IRF4 under a Doxycycline inducible promoter
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 123323 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCW-MCS-Puro
- Total vector size (bp) 9038
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Stbl3
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameIRF4
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1356
-
Mutationseveral silent mutations to disrupt sgRNA targeting
-
Entrez GeneIRF4 (a.k.a. LSIRF, MUM1, NF-EM5, SHEP8)
- Promoter Doxycycline inducible minimal CMV
Cloning Information
- Cloning method Gibson Cloning
- 5′ sequencing primer -
- 3′ sequencing primer - (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCW-IRF4-Puro was a gift from Eva Gottwein (Addgene plasmid # 123323 ; http://n2t.net/addgene:123323 ; RRID:Addgene_123323) -
For your References section:
CK1alpha and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma. Patil A, Manzano M, Gottwein E. Blood. 2018 Aug 9;132(6):577-586. doi: 10.1182/blood-2018-01-828418. Epub 2018 Jun 28. 10.1182/blood-2018-01-828418 PubMed 29954751